Last Price
0.053
Today's Change
+0.007 (15.21%)
Day's Change
0.047 - 0.058
Trading Volume
35,999,474
Overview
Market Cap
32 Million
Shares Outstanding
611 Million
Avg Volume
3,190,241
Avg Price (50 Days)
0.04
Avg Price (200 Days)
0.03
PE Ratio
-1.77
EPS
-0.03
Earnings Announcement
02-Sep-2025
Previous Close
0.05
Open
0.05
Day's Range
0.047 - 0.058
Year Range
0.021 - 0.058
Trading Volume
35,999,474
Price Change Highlight
1 Day Change
15.22%
5 Day Change
26.19%
1 Month Change
29.27%
3 Month Change
70.97%
6 Month Change
65.62%
Ytd Change
47.22%
1 Year Change
65.62%
3 Year Change
-77.14%
5 Year Change
-44.58%
10 Year Change
-62.16%
Max Change
-62.16%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Health Information Services
Description:
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now